Concepts (166)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Dairy Products | 3 | 2021 | 493 | 1.290 |
Why?
|
Vitamin D | 8 | 2014 | 3177 | 0.940 |
Why?
|
Diabetes Mellitus, Type 2 | 16 | 2023 | 11403 | 0.920 |
Why?
|
Fatty Acids, Nonesterified | 1 | 2021 | 406 | 0.700 |
Why?
|
Diabetes Mellitus | 7 | 2023 | 5522 | 0.680 |
Why?
|
Diet, Fat-Restricted | 1 | 2020 | 311 | 0.630 |
Why?
|
Glycemic Index | 2 | 2019 | 395 | 0.630 |
Why?
|
Nutrition Assessment | 1 | 2021 | 721 | 0.630 |
Why?
|
Maternal Nutritional Physiological Phenomena | 1 | 2019 | 376 | 0.560 |
Why?
|
Leukemia | 2 | 2012 | 1495 | 0.480 |
Why?
|
Lymphoma, Non-Hodgkin | 2 | 2012 | 1384 | 0.450 |
Why?
|
Hyperglycemia | 4 | 2023 | 1337 | 0.420 |
Why?
|
Calcium, Dietary | 2 | 2011 | 526 | 0.410 |
Why?
|
Overweight | 4 | 2018 | 2285 | 0.390 |
Why?
|
Diabetes, Gestational | 1 | 2019 | 1136 | 0.370 |
Why?
|
Lipids | 2 | 2023 | 3299 | 0.370 |
Why?
|
Body Weight | 4 | 2021 | 4657 | 0.370 |
Why?
|
Blood Glucose | 7 | 2023 | 6212 | 0.350 |
Why?
|
Dyslipidemias | 1 | 2016 | 840 | 0.350 |
Why?
|
Endocrinology | 2 | 2014 | 415 | 0.340 |
Why?
|
Feeding Behavior | 1 | 2019 | 3166 | 0.290 |
Why?
|
Obesity | 5 | 2020 | 12420 | 0.280 |
Why?
|
Cardiovascular Diseases | 7 | 2022 | 14701 | 0.280 |
Why?
|
Dietary Supplements | 4 | 2014 | 3227 | 0.260 |
Why?
|
Diet | 2 | 2021 | 7797 | 0.260 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 1 | 2013 | 1320 | 0.240 |
Why?
|
Vitamins | 2 | 2014 | 1561 | 0.240 |
Why?
|
Insulin-Secreting Cells | 1 | 2011 | 875 | 0.240 |
Why?
|
Insulin Resistance | 3 | 2014 | 3872 | 0.240 |
Why?
|
Risk Factors | 16 | 2022 | 70971 | 0.240 |
Why?
|
Energy Intake | 2 | 2020 | 2148 | 0.210 |
Why?
|
Aerobiosis | 1 | 2020 | 106 | 0.190 |
Why?
|
Fenofibrate | 1 | 2020 | 89 | 0.190 |
Why?
|
Hypoglycemic Agents | 2 | 2009 | 2766 | 0.190 |
Why?
|
Insulin | 3 | 2011 | 6562 | 0.190 |
Why?
|
Malaysia | 1 | 2019 | 86 | 0.180 |
Why?
|
Weight Gain | 1 | 2009 | 2238 | 0.170 |
Why?
|
Diabetes Mellitus, Type 1 | 1 | 2013 | 3298 | 0.170 |
Why?
|
Practice Guidelines as Topic | 1 | 2016 | 7256 | 0.170 |
Why?
|
Hypertension | 2 | 2016 | 8250 | 0.170 |
Why?
|
Diet Therapy | 1 | 2019 | 153 | 0.170 |
Why?
|
Blood Pressure | 4 | 2023 | 8464 | 0.160 |
Why?
|
Nutritional Physiological Phenomena | 1 | 2020 | 370 | 0.160 |
Why?
|
Randomized Controlled Trials as Topic | 6 | 2016 | 9589 | 0.160 |
Why?
|
Cholesterol, LDL | 2 | 2017 | 2319 | 0.150 |
Why?
|
Waist Circumference | 3 | 2019 | 908 | 0.150 |
Why?
|
Dietary Carbohydrates | 2 | 2019 | 899 | 0.150 |
Why?
|
Nutrition Therapy | 1 | 2018 | 95 | 0.150 |
Why?
|
Physical Conditioning, Animal | 1 | 2020 | 356 | 0.150 |
Why?
|
Cohort Studies | 5 | 2019 | 39883 | 0.140 |
Why?
|
Food, Formulated | 1 | 2016 | 111 | 0.140 |
Why?
|
Humans | 32 | 2023 | 725001 | 0.140 |
Why?
|
Dietary Fiber | 1 | 2019 | 757 | 0.130 |
Why?
|
Pregnant Women | 1 | 2019 | 543 | 0.130 |
Why?
|
Multiple Myeloma | 1 | 2012 | 5066 | 0.120 |
Why?
|
Middle Aged | 14 | 2023 | 212155 | 0.120 |
Why?
|
Adaptation, Physiological | 1 | 2020 | 1327 | 0.120 |
Why?
|
Eating | 1 | 2020 | 1524 | 0.110 |
Why?
|
Hyperinsulinism | 1 | 2016 | 414 | 0.110 |
Why?
|
Female | 19 | 2023 | 375303 | 0.110 |
Why?
|
Vitamin D Deficiency | 2 | 2014 | 1340 | 0.110 |
Why?
|
Glucose Intolerance | 2 | 2020 | 582 | 0.110 |
Why?
|
Hyperlipoproteinemia Type II | 1 | 2017 | 372 | 0.110 |
Why?
|
Refugees | 1 | 2019 | 494 | 0.110 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2017 | 3169 | 0.110 |
Why?
|
Dietary Fats | 1 | 2020 | 2038 | 0.110 |
Why?
|
Glucagon-Like Peptide 1 | 2 | 2016 | 331 | 0.110 |
Why?
|
Endocrine System Diseases | 1 | 2014 | 248 | 0.110 |
Why?
|
Male | 17 | 2023 | 346964 | 0.100 |
Why?
|
Body Mass Index | 4 | 2023 | 12527 | 0.100 |
Why?
|
Adult | 11 | 2020 | 211523 | 0.100 |
Why?
|
Hyperlipidemias | 1 | 2016 | 786 | 0.100 |
Why?
|
Diabetic Angiopathies | 1 | 2016 | 819 | 0.100 |
Why?
|
Income | 1 | 2019 | 1830 | 0.100 |
Why?
|
Incidence | 3 | 2014 | 20743 | 0.090 |
Why?
|
Dipeptidyl Peptidase 4 | 1 | 2009 | 91 | 0.090 |
Why?
|
Cholecalciferol | 1 | 2014 | 521 | 0.090 |
Why?
|
Venoms | 1 | 2009 | 92 | 0.090 |
Why?
|
Prediabetic State | 1 | 2014 | 476 | 0.090 |
Why?
|
Muscle, Skeletal | 2 | 2022 | 4956 | 0.080 |
Why?
|
Sulfonylurea Compounds | 1 | 2009 | 186 | 0.080 |
Why?
|
Young Adult | 4 | 2020 | 55791 | 0.080 |
Why?
|
Delivery of Health Care, Integrated | 1 | 2016 | 946 | 0.080 |
Why?
|
Aged | 9 | 2023 | 161379 | 0.080 |
Why?
|
Abdominal Fat | 1 | 2009 | 221 | 0.080 |
Why?
|
Fasting | 1 | 2014 | 1587 | 0.080 |
Why?
|
Consensus | 1 | 2016 | 2821 | 0.080 |
Why?
|
Coronary Disease | 1 | 2022 | 6082 | 0.080 |
Why?
|
Double-Blind Method | 2 | 2011 | 11885 | 0.070 |
Why?
|
Life Style | 2 | 2018 | 3780 | 0.070 |
Why?
|
Meta-Analysis as Topic | 1 | 2011 | 1335 | 0.070 |
Why?
|
Thiazolidinediones | 1 | 2009 | 474 | 0.070 |
Why?
|
Health Status Disparities | 1 | 2017 | 1738 | 0.070 |
Why?
|
Dipeptidyl-Peptidase IV Inhibitors | 1 | 2009 | 264 | 0.070 |
Why?
|
Administration, Inhalation | 1 | 2008 | 1113 | 0.070 |
Why?
|
Case-Control Studies | 2 | 2013 | 21575 | 0.060 |
Why?
|
Exercise | 1 | 2020 | 5489 | 0.060 |
Why?
|
Diet, Reducing | 2 | 2018 | 454 | 0.060 |
Why?
|
Benzamides | 1 | 2009 | 1372 | 0.060 |
Why?
|
Regression Analysis | 1 | 2013 | 6434 | 0.060 |
Why?
|
Nutrition Surveys | 1 | 2010 | 1606 | 0.060 |
Why?
|
Metformin | 1 | 2009 | 805 | 0.060 |
Why?
|
Cholesterol, HDL | 2 | 2020 | 1797 | 0.050 |
Why?
|
Streptozocin | 1 | 2022 | 198 | 0.050 |
Why?
|
Uridine | 1 | 2022 | 140 | 0.050 |
Why?
|
United States | 3 | 2016 | 68433 | 0.050 |
Why?
|
Chronic Disease | 1 | 2016 | 9026 | 0.050 |
Why?
|
Prospective Studies | 5 | 2022 | 51853 | 0.050 |
Why?
|
Data Interpretation, Statistical | 1 | 2011 | 2726 | 0.050 |
Why?
|
Health Status | 1 | 2014 | 3984 | 0.050 |
Why?
|
Anaerobic Threshold | 1 | 2020 | 52 | 0.050 |
Why?
|
Glucose | 2 | 2023 | 4315 | 0.050 |
Why?
|
Heart Failure | 1 | 2023 | 10378 | 0.040 |
Why?
|
Albuminuria | 1 | 2023 | 667 | 0.040 |
Why?
|
Middle East | 1 | 2019 | 206 | 0.040 |
Why?
|
United Nations | 1 | 2019 | 155 | 0.040 |
Why?
|
Risk | 1 | 2011 | 9697 | 0.040 |
Why?
|
Survival Analysis | 1 | 2012 | 10244 | 0.040 |
Why?
|
JNK Mitogen-Activated Protein Kinases | 1 | 2020 | 462 | 0.040 |
Why?
|
Weight Loss | 1 | 2009 | 2521 | 0.040 |
Why?
|
Pregnancy | 1 | 2019 | 28148 | 0.040 |
Why?
|
Arabs | 1 | 2019 | 165 | 0.040 |
Why?
|
Adolescent | 2 | 2019 | 84411 | 0.040 |
Why?
|
Peptides | 1 | 2009 | 4388 | 0.040 |
Why?
|
Signal Transduction | 1 | 2020 | 23445 | 0.040 |
Why?
|
Prevalence | 1 | 2014 | 14951 | 0.040 |
Why?
|
Seeds | 1 | 2016 | 104 | 0.040 |
Why?
|
Glomerular Filtration Rate | 1 | 2023 | 2127 | 0.030 |
Why?
|
Dietary Fats, Unsaturated | 1 | 2016 | 228 | 0.030 |
Why?
|
Sex Factors | 2 | 2020 | 10385 | 0.030 |
Why?
|
Extracellular Matrix | 1 | 2022 | 1762 | 0.030 |
Why?
|
Enzyme Activation | 1 | 2020 | 3739 | 0.030 |
Why?
|
Metabolomics | 1 | 2022 | 1422 | 0.030 |
Why?
|
Clinical Trials as Topic | 1 | 2009 | 7835 | 0.030 |
Why?
|
Cross-Sectional Studies | 1 | 2014 | 24043 | 0.030 |
Why?
|
Multicenter Studies as Topic | 1 | 2017 | 1532 | 0.030 |
Why?
|
Hyperparathyroidism | 1 | 2014 | 338 | 0.030 |
Why?
|
Risk Reduction Behavior | 1 | 2019 | 1121 | 0.030 |
Why?
|
Graves Disease | 1 | 2014 | 243 | 0.030 |
Why?
|
Behavior Therapy | 1 | 2018 | 854 | 0.030 |
Why?
|
Motor Activity | 1 | 2022 | 2714 | 0.030 |
Why?
|
Algorithms | 1 | 2012 | 13759 | 0.030 |
Why?
|
Cross-Over Studies | 1 | 2016 | 2027 | 0.020 |
Why?
|
Polycystic Ovary Syndrome | 1 | 2014 | 352 | 0.020 |
Why?
|
Counseling | 1 | 2018 | 1495 | 0.020 |
Why?
|
Lung | 1 | 2008 | 9812 | 0.020 |
Why?
|
Follow-Up Studies | 1 | 2011 | 38720 | 0.020 |
Why?
|
Hospital Mortality | 1 | 2023 | 5222 | 0.020 |
Why?
|
Body Composition | 1 | 2018 | 2416 | 0.020 |
Why?
|
Kidney | 1 | 2023 | 7022 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2020 | 3377 | 0.020 |
Why?
|
Risk Assessment | 1 | 2008 | 23178 | 0.020 |
Why?
|
Odds Ratio | 1 | 2017 | 9837 | 0.020 |
Why?
|
Mice | 2 | 2022 | 80318 | 0.020 |
Why?
|
Rats | 1 | 2020 | 24422 | 0.010 |
Why?
|
Hospitalization | 1 | 2023 | 9956 | 0.010 |
Why?
|
Homeostasis | 1 | 2014 | 3330 | 0.010 |
Why?
|
Animals | 3 | 2022 | 168735 | 0.010 |
Why?
|
Healthcare Disparities | 1 | 2017 | 3065 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2023 | 74145 | 0.010 |
Why?
|
Registries | 1 | 2017 | 7910 | 0.010 |
Why?
|
Phenotype | 1 | 2017 | 16262 | 0.010 |
Why?
|
Aged, 80 and over | 1 | 2023 | 57615 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2012 | 12318 | 0.010 |
Why?
|
Longitudinal Studies | 1 | 2010 | 13692 | 0.010 |
Why?
|
Treatment Outcome | 1 | 2018 | 61674 | 0.010 |
Why?
|
Concepts
(166)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(22)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_